Dr. Zamah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 312-996-4238
Summary
- Dr. Zamah is an REI specialist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his MD and PhD from Duke University School of Medicine and has been in practice 14 years. He completed his residency in OBGYN at Stanford University Hospital and his REI fellowship training at UCSF Medical Center. He specializes in reproductive endocrinology & infertility. He has more than 20 publications and over 500 citations.
Education & Training
- University of California (San Francisco)Fellowship, Reproductive Endocrinology and Infertility, 2007 - 2010
- Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 2003 - 2007
- Duke University School of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2004 - Present
- IL State Medical License 2013 - 2026
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- 24 citationsFollicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injectionJulie D. Lamb, A. Musa Zamah, Shehua Shen, Charles E. McCulloch, Marcelle I. Cedars
Fertility and Sterility. 2010-08-01 - 31 citationsThe effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery.Mitchell P. Rosen, A. Musa Zamah, Shehua Shen, A.T. Dobson, Charles E. McCulloch
Reproductive Biology and Endocrinology. 2009-04-23 - 27 citationsA novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders.Hakan Cakmak, Nam D. Tran, A. Musa Zamah, Marcelle I. Cedars, Mitchell P. Rosen
Fertility and Sterility. 2014-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: